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We read with great interest the paper by Menting et al.
about the use of remote ischemic preconditioning (RIPC) to
reduce contrast medium induced nephropathy (CIN) in pa-
tients at risk of CIN.1 Their results in a group at high risk of
CIN are in line with results from Er et al. who showed that
use of such a procedure could reduce CIN in high risk pa-
tients. Er et al. identiﬁed CIN in 20 patients in their control
group, but only six in their RIPC group (p ¼ .002).2 In both
studies, RIPC was performed as an adjunct to hydration.
However, in our opinion, the role of hydration requires
further discussion, especially where different hydration
protocols are performed. Zarbock et al. showed that RIPC
alone reduced the rate of acute kidney injury and the use of
renal replacement therapy among high risk patients un-
dergoing cardiac surgery.3 Therefore, the question remains
whether or not RIPC should be used as an adjunct or alone?
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Their question, if remote ischemic preconditioning is suf-
ﬁcient on its own to prevent contrast medium induced
nephropathy (CIN), cannot be answered with current
literature data. In patients undergoing major (non-)cardiac
surgery the efﬁcacy of remote ischemic preconditioning
(RIPC) remains unclear. Some randomized controlled trials
showed a reduction in surgery related acute kidney injury
(AKI),1,2 whereas others could not conﬁrm this.3,4
Regarding the use of remote ischemic preconditioning in
patients receiving intravascular contrast media, we feel
that there is now suggestive evidence that remote
ischemic preconditioning when added to hydration may
prevent CIN.5,6 However, the routine use of added RIPC in
unselected patients cannot be advocated, and better
identiﬁcation of high risk patients is needed. Since hy-
dration is proven to be effective in preventing CIN, and
dehydration is associated with higher risk of AKI we would
argue against the use of ischemic preconditioning alone in
such high risk patients. However, we envisage that RIPC
alone may be sufﬁcient to prevent CIN in intermediate risk
patients, and could be used to replace intravenous sodium
chloride or intravenous sodium bicarbonate. Controlled
studies are needed to explore the best strategies for the
prevention of CIN.
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